PlainRecalls
FDA Drug Critical Class I Ongoing

libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.

Reported: May 1, 2024 Initiated: March 19, 2024 #D-0454-2024

Product Description

libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.

Reason for Recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Details

Recalling Firm
Pyramids Wholesale Inc.
Units Affected
7 boxes
Distribution
Nationwide in the USA
Location
Los Angeles, CA

Frequently Asked Questions

What product was recalled?
libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.. Recalled by Pyramids Wholesale Inc.. Units affected: 7 boxes.
Why was this product recalled?
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2024. Severity: Critical. Recall number: D-0454-2024.